The U.S. Food and Drug Administration (FDA) has an entry for application number ANDA080493. The application pertains to an oral tablet formulation of CORTISONE ACETATE, 25 mg per tablet, submitted by Purepac Pharm.
According to the FDA data, the product (product number 001) is listed as discontinued, is not a reference drug, and has no reference standard indicated.
規制動向2026年9月16日•3分で読めます
FDA Lists ANDA080493 for Purepac CORTISONE ACETATE Oral Tablet (Discontinued)
The FDA entry ANDA080493 shows Purepac Pharm's oral CORTISONE ACETATE 25 mg tablet is listed as discontinued.
Pharmacountryチームがまとめました · 出典： FDA.gov
トピック：
評価
(0)
(0)
(0)
(0)
(0)
評価を残す